India is positioning itself as a major player in the next phase of global genomic science. The Genomics India Conference (GIC) 2026, scheduled for September 2-3 in Bengaluru, will bring together international genomics pioneers, policymakers, and researchers to discuss how India can contribute to Human Genome Project II (HGP2) and launch its own large-scale sequencing initiative representing the country's genetic diversity.

What Is Human Genome Project II and Why Does It Matter for India?

Human Genome Project II represents an ambitious global effort to sequence at least one percent of the world's population and apply genomic knowledge to advance precision public health. For India, participation in HGP2 offers a unique opportunity to ensure that the country's extraordinary genetic diversity is represented in global genomic databases, which have historically been skewed toward European populations. A major focus of GIC 2026 will be exploring how India can contribute to this international initiative while simultaneously building infrastructure for precision medicine, public health research, and a genomics-driven bioeconomy.

"Human Genome Project II presents an important opportunity to build a more inclusive global understanding of human genomic diversity. GIC 2026 will provide a timely platform to examine how India can contribute to this effort and shape a large-scale sequencing programme that represents the extraordinary genetic diversity of its population," stated Dr. Raja Mugasimangalam, Founder and CEO of Genotypic Technology.

Dr. Raja Mugasimangalam, Founder and CEO, Genotypic Technology

Who Are the Global Leaders Speaking at the Conference?

GIC 2026 will feature three internationally recognized keynote speakers whose work spans the foundational science of genome analysis to the development of global genomic infrastructure. The conference will welcome Prof. Charles R. Cantor from Boston University, one of the founding architects of human genome science whose pioneering research established many of the foundational methodologies that underpin modern genomics and molecular diagnostics. Prof. Michael P. Snyder from Stanford University, a global leader in functional genomics and personalized medicine, will discuss how artificial intelligence and wearable technologies are transforming healthcare toward continuous, predictive and preventive models. Dr. Weibin Liu, Vice President of BGI Group and co-initiator of Human Genome Project II, will address the transition from large-scale genomic data generation to public-health applications and bioeconomic value creation.

Dr. Beena Pillai, Director of BRIC-Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, will deliver the inaugural lecture, formally opening the conference and setting the stage for two days of scientific and strategic discussions on translating genomic discoveries into real-world applications.

How to Prepare for the Conference's Key Topics and Workshops

GIC 2026 will offer seven specialized pre-conference workshops on September 1, 2026, designed to equip researchers and professionals with cutting-edge skills in genomics and artificial intelligence. These workshops will cover:

• Statistical Genomics: Hosted by the National Centre for Biological Sciences, this workshop will focus on statistical methods essential for analyzing large-scale genomic datasets.
• AI-Driven Multi-Omics: Conducted by the Indian Institute of Science, this workshop will explore how artificial intelligence is being applied to analyze multiple layers of biological data simultaneously, including genes, proteins, and metabolites.
• AI-Driven NGS Data Analysis: Genotypic Technology will lead this workshop on using artificial intelligence to process next-generation sequencing data, a critical skill as sequencing volumes increase exponentially.
• Metagenomics for Clinical and Environmental Applications: The Tata Institute for Genetics and Society will teach participants how to analyze microbial communities in clinical and environmental samples.
• Phenomics and Hologenomics in Modern Agriculture: The University of Agricultural Sciences will demonstrate how genomic approaches are transforming crop improvement and agricultural productivity.
• Long-Read Sequencing Using Agilent Target Enrichment: Agilent Technologies will provide hands-on training in advanced sequencing technologies that can read longer stretches of DNA.
• From FASTQ to Actionable Insight: Meril Genomics will demonstrate a multi-omics bioinformatics workbench that converts raw sequencing data into clinically actionable insights.

The conference program will span human health and precision medicine, population genomics, multi-omics, artificial intelligence, agriculture, metagenomics, diagnostics, bioinformatics, and the broader genomics bioeconomy. More than 60 speakers, session chairs, and panelists from leading research institutions, universities, hospitals, and genomics organizations in India and overseas will participate.

Why Is India's Genomic Diversity Critical for Global Science?

India's genetic diversity is one of the world's richest, reflecting thousands of years of human migration, settlement, and adaptation across vastly different climates and environments. However, most global genomic databases have been built primarily from European and East Asian populations, creating significant blind spots in our understanding of human genetic variation. By launching a large-scale sequencing program that captures India's population diversity, the country can contribute to a more complete and representative picture of human genomics. This has profound implications for precision medicine, as genetic variants that are rare in European populations may be common in Indian populations, affecting drug metabolism, disease risk, and treatment response.

"We are honoured to welcome Prof Charles Cantor, Prof Michael Snyder and Dr Weibin Liu to GIC 2026. Together, they represent the full arc of genomics, from the foundational science that made the genome readable and the multi-omics revolution transforming medicine to the global infrastructure now scaling genomics into a true bioeconomy. That arc is exactly what GIC 2026 is about," explained Dr. Raja Mugasimangalam.

Dr. Raja Mugasimangalam, Founder and CEO, Genotypic Technology

The conference is being jointly organized by Genotypic Technology, the University of Agricultural Sciences, the National Centre for Biological Sciences, the Indian Institute of Science, and the Tata Institute for Genetics and Society. Participating institutions also include CSIR-Centre for Cellular and Molecular Biology, BRIC-Centre for DNA Fingerprinting and Diagnostics, IIT Roorkee, and the Indian Institute of Science Education and Research Kolkata, among others.

GIC 2026 represents a pivotal moment for India's genomics ecosystem. As the country positions itself to participate in Human Genome Project II and build its own large-scale sequencing infrastructure, the conference will serve as a crucial forum for aligning scientific ambition with policy support, industry investment, and international collaboration. The theme, "Genome to Bioeconomy: Innovation, Impact and Economic Transformation," captures the broader vision of translating genomic science into measurable healthcare, agricultural, environmental, and economic benefits for India and the world.

" }